SHZ · 300439.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Medicalsystem Biotechnology Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 14.58% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Medicalsystem Biotechnology Co., Ltd.’s forward annual dividend is CN¥0.03 per share, paid annual. The forward yield is 0.35% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Medicalsystem Biotechnology Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Medicalsystem Biotechnology Co., Ltd. is a Chinese company focused on delivering clinical diagnostic solutions. Their comprehensive product line includes a full array of reagents and instruments designed for COVID-19 detection, such as PCR, antibody, and antigen test kits, alongside nucleic acid reagents. Beyond infectious disease diagnostics, the company also supplies advanced medical equipment like automated biochemistry analyzers (complete with their corresponding bio-reagents), hematology analyzers, urine analyzers, and glycated hemoglobin analyzers. Additionally, their offerings extend to Point-of-Care Testing (POCT) devices and cutting-edge chemiluminescence immunoassay analyzers. In addition to its diagnostic product offerings, Medicalsystem also provides healthcare services. Initially established in 2003 as Ningbo Medicalsystem Biotechnology Co., Ltd., the company officially adopted its current name, Medicalsystem Biotechnology Co., Ltd., in January 2017. Its corporate headquarters are situated in Ningbo, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥10.15+CN¥0.16 (+1.6%)
Shanghai Labway Clinical Laboratory Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 30.24% below the high.
CN¥13.44-CN¥0.66 (-4.68%)
Ningbo David Medical Device Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 20.47% below the high.
CN¥17.27-CN¥0.27 (-1.54%)
Zhejiang Gongdong Medical Technology Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 23.85% below the high.
CN¥5.73-CN¥0.10 (-1.72%)
Guangdong Hybribio Biotech Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.1% below the high.
CN¥10.72-CN¥0.75 (-6.54%)
Cachet Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 45.56% below the high.
CN¥10.69+CN¥0.04 (+0.38%)
Well Lead Medical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 34.9% below the high.
CN¥7.11+CN¥0.11 (+1.57%)
Shanghai Kindly Enterprise Development Group Co.,LTD.’s quoted price sits in the lower half of its reported 52-week range, 25.94% below the high.
CN¥5.69-CN¥0.18 (-3.07%)
Chemclin Diagnostics Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.45% below the high.
